You’re reading free news for NRXS. Sign up free for 3 full 5D deep-dives a month, or start a 14-day Pro trial to unlock the full 5D analysis on more than 3,000 US-listed stocks - no credit card required.

NeurAxis, Inc.· NRXS

🇺🇸 US · MicroBroad USAMEX

Healthcare Biotechnology Website

Price: $7.40
Day: -2.63%
Mkt Cap: $92.93M
52W Range: $2.21 – $9.33
Volume: 75.2K
Beta: 1.36

News and Reports

Breaking news, press releases, and analyst updates.

Company news, Oct 15, 2026: NeurAxis Announces Medical Policy Coverage Milestone, Expanding…
Analyst rating, Dec 22, 2025: Neuraxis price target raised to $8 from $7 at Craig-Hallum
Price target, Jun 16, 2025: Neuraxis initiated with a Buy at Craig-Hallum

NRXS Latest News

Most recent articles and analysis covering this company.

NRXSGlobeNewsWireOct 15, 2026

NeurAxis Announces Medical Policy Coverage Milestone, Expanding Access to 26 Million Additional Covered Lives

Total national coverage footprint for PENFS increases to over 147 million covered lives Total national coverage footprint for PENFS increases to over 147 million covered lives

globenewswire.comRead the article

Also in the news

Defense WorldOct 12, 2026
Reviewing NeurAxis (NASDAQ:NRXS) and NovoCure (NASDAQ:NVCR)
Defense WorldOct 5, 2026
Financial Review: Solventum (NYSE:SOLV) vs. NeurAxis (NASDAQ:NRXS)

NeurAxis, Inc.· NRXS

News and Reports

NRXS Latest News

NeurAxis Announces Medical Policy Coverage Milestone, Expanding Access to 26 Million Additional Covered Lives

Reviewing NeurAxis (NASDAQ:NRXS) and NovoCure (NASDAQ:NVCR)

Financial Review: Solventum (NYSE:SOLV) vs. NeurAxis (NASDAQ:NRXS)

Search stocks

News and Reports

NRXS Latest News

NeurAxis Announces Medical Policy Coverage Milestone, Expanding Access to 26 Million Additional Covered Lives

Reviewing NeurAxis (NASDAQ:NRXS) and NovoCure (NASDAQ:NVCR)

Financial Review: Solventum (NYSE:SOLV) vs. NeurAxis (NASDAQ:NRXS)